Sign in

CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6462005278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-06-01 Dunlap Ryan Former Chief Financial Officer Option exercise · Stock Option −30,000 0
2016-04-25 GRAY MARY ANN Director Grant or award · Stock Option (right to buy) +200,000 200,000
2016-02-23 Burns John Thomas Principal Accounting Officer Grant or award · Stock Option (right to buy) +75,000 75,000
2015-12-18 Nejadnik Bijan Executive VP and CMO Grant or award · Stock Option (right to buy) +50,000 50,000
2015-12-18 Knapp Thomas J General Counsel Grant or award · Stock Option (right to buy) +225,000 225,000
2015-12-18 SCHWARTZ MARK W. President and CEO Grant or award · Stock Option (right to buy) +1,250,000 1,250,000
2015-10-30 Nejadnik Bijan Executive VP and CMO Grant or award · Stock Option (right to buy) +350,000 350,000
2015-06-25 Knapp Thomas J General Counsel Grant or award · Stock Option (right to buy) +40,000 40,000
2015-06-19 GALLIKER STEPHEN S Director Grant or award · Stock Option (right to buy) +100,000 100,000
2015-06-19 Einhorn Irving M. Director Grant or award · Stock Option (right to buy) +100,000 100,000
2015-06-19 KRIEGSMAN STEVEN A Director Grant or award · Stock Option (right to buy) +100,000 100,000
2015-06-19 Hillsberg Sanford Director Grant or award · Stock Option (right to buy) +100,000 100,000
2015-06-19 Nisi Rudolph Director Grant or award · Stock Option (right to buy) +100,000 100,000
2015-06-19 Chin Richard Director Grant or award · Stock Option (right to buy) +100,000 100,000
2015-06-19 Ashton William Director Grant or award · Stock Option (right to buy) +100,000 100,000
2015-01-16 SCHWARTZ MARK W. President & CEO Grant or award · Stock Option (right to buy) +550,000 550,000
2015-01-16 Dunlap Ryan VP, Chief Financial Officer Grant or award · Stock Option (right to buy) +125,000 125,000
2015-01-16 Kivinski Margaret VP and General Counsel Grant or award · Stock Option (right to buy) +50,000 50,000
2014-12-31 SCHWARTZ MARK W. President & CEO Other acquisition +3,846 $1.28 $5K 415,972
2014-12-31 Dunlap Ryan VP, Chief Financial Officer Other acquisition +3,846 $1.28 $5K 11,650

Page 12 of 17 · 324 trades